TNF-alpha-treated DC exacerbates disease in a murine tumor metastasis model

Cancer Immunology, Immunotherapy

Volumn 59, Issue 5, 2010, Pages 729-736

  Vohra, Nasreen ^a,b   Verhaegen, Monique ^c   Martin, Lisa ^a   Mackay, Amy ^a   Pilon Thomas, Shari ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Dendritic cells melanoma; Immunotherapy; TNF alpha

Indexed keywords

DENDRITIC CELL VACCINE; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ CD25+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE EXACERBATION; FEMALE; IMMUNOLOGICAL TOLERANCE; KNOCKOUT MOUSE; LUNG METASTASIS; LYMPHOCYTIC INFILTRATION; MELANOMA B16; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; ANIMAL; C57BL MOUSE; CD4+ T LYMPHOCYTE; CELL SEPARATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MELANOMA; FLOW CYTOMETRY; IMMUNOLOGY; IMMUNOTHERAPY; LUNG TUMOR; METASTASIS; METHODOLOGY; MOUSE MUTANT; PATHOLOGY; SECRETION; T LYMPHOCYTE SUBPOPULATION; TRANSPLANTATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNE TOLERANCE; IMMUNOTHERAPY; INTERLEUKIN-10; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASM METASTASIS; T-LYMPHOCYTE SUBSETS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77950476564     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-009-0793-5     Document Type: Article

References (43)

1. Steinman R, Inaba K (1989) Immunogenicity: role of dendritic cells. Bioessays 10:145-152
2. Banchereau J, Steinman RM. (1998) Dendritic cells and the control of immunity. Nature 392:245-252
3. Steinman RM (2006) Linking innate to adaptive immunity through dendritic cells. Novartis Found symp 279:101-109 (discussion 109-113, 216-109)
4. Steinman RM, Turley S, Mellman I, Inaba K (2000) The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 191:411-416
5. Steinman RM, Hawiger D, Nussenzweig MC (2003) Tolerogenic dendritic cells. Annu Rev Immunol 21:685-711
6. Cools N, Ponsaerts P, Van Tendeloo VF, Berneman ZN (2007) Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells. J Leukoc Biol 82:1365-1374 (Pubitemid 350276946)
7. Tan JK, O'Neill HC (2005) Maturation requirements for dendritic cells in T-cell stimulation leading to tolerance versus immunity. J Leukoc Biol 78:319-324
8. Mellman I, Steinman RM (2001) Dendritic cells: specialized and regulated antigen-processing machines. Cell 106:255-258 (Pubitemid 32772607)
9. Fields RC, Shimizu K, Mulé JJ (1998) Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc Natl Acad Sci USA 95:9482-9487 (Pubitemid 28506257)
10. Kotera Y, Shimizu K, Mulé JJ (2001) Comparative analysis of necrotic and apoptotic tumor cells as a source of antigen(s) in dendritic cell-based immunization. Cancer Res 61:8105-8109 (Pubitemid 33091598)
11. Nestle FO, Alijagic S, Gilliet M, Sun Y, Grabbe S, Dummer R, Burg G, Schadendorf D (1998) Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 4:328-332 (Pubitemid 28144092)
12. Geiger JD, Hutchinson RJ, Hohenkirk LF, McKenna EA, Yanik GA, Levine JE, Chang AE, Braun TM, Mulé JJ (2001) Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression. Cancer Res 61:8513-8519
13. Chang AE, Redman BG, Whitfield JR, Nickoloff BJ, Braun TM, Lee PP, Geiger JD, Mulé JJ (2002) A phase I trial of tumor lysate-pulsed dendritic cells in the treatment of advanced cancer. Clin Cancer Res 8:1021-1032
14. Pilon-Thomas S, Li W, Briggs JJ, Djeu J, Mulé JJ, Riker AI (2006) Immunostimulatory effects of CpG-ODN upon dendritic cell-based immunotherapy in a murine melanoma model. J Immunother 29:381-387 (Pubitemid 44288950)
15. De Smedt T, Pajak B, Muraille E, Lespagnard L, Heinen E, De Baetselier P, Urbain J, Leo O, Moser M (1996) Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med 184:1413-1424
16. Sallusto F, Schaerli P, Loetscher P, Schaniel C, Lenig D, Mackay CR, Qin S, Lanzavecchia A (1998) Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 28:2760-2769 (Pubitemid 28425234)
17. Brunner C, Seiderer J, Schlamp A, Bidlingmaier M, Eigler A, Haimerl W, Lehr HA, Krieg AM, Hartmann G, Endres S (2000) Enhanced dendritic cell maturation by TNF-alpha or cytidinephosphate-guanosine DNA drives T-cell activation in vitro and therapeutic anti-tumor immune responses in vivo. J Immunol 165:6278-6286
18. Labeur MS, Roters B, Pers B, Mehling A, Luger TA, Schwarz T, Grabbe S (1999) Generation of tumor immunity by bone marrowderived dendritic cells correlates with dendritic cell maturation stage. J Immunol 162:168-175 (Pubitemid 29018917)
19. Granucci F, Vizzardelli C, Virzi E, Rescigno M, RicciardiCastagnoli P (2001) Transcriptional reprogramming of dendritic cells by differentiation stimuli. Eur J Immunol 31:2539-2546 (Pubitemid 32898720)
20. Nelson EL, Strobl S, Subleski J, Prieto D, Kopp WC, Nelson PJ (1999) Cycling of human dendritic cell effector phenotypes in response to TNF-alpha: modification of the current 'maturation' paradigm and implications for in vivo immunoregulation. Faseb J 13:2021-2030
21. Lutz MB, Schuler G (2002) Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 23:445-449
22. Hawiger D, Inaba K, Dorsett Y, Guo M, Mahnke K, Rivera M, Ravetch JV, Steinman RM, Nussenzweig MC (2001) Dendritic cells induce peripheral T-cell unresponsiveness under steadystate conditions in vivo. J Exp Med 194:769-779 (Pubitemid 32983013)
23. Menges M, Rossner S, Voigtlander C, Schindler H, Kukutsch NA, Bogdan C, Erb K, Schuler G, Lutz MB (2002) Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J Exp Med 195:15-21 (Pubitemid 34074492)
24. Verginis P, Li HS, Carayanniotis G (2005) Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4 + CD25 + T cells. J Immunol 174:7433-7439 (Pubitemid 40705715)
25. van Duivenvoorde LM, Louis-Plence P, Apparailly F, van der Voort EI, Huizinga TW, Jorgensen C, Toes RE (2004) Antigenspecific immunomodulation of collagen-induced arthritis with tumor necrosis factor-stimulated dendritic cells. Arthritis Rheum 50:3354-3364 (Pubitemid 39372014)
26. Area MJ, Krauss JC, Aruga A, Cameron MJ, Shu S, Chang AE (1996) Therapeutic efficacy of T cells derived from lymph nodes draining a poorly immunogenic tumor transduced to secrete granulocyte-macrophage colony-stimulating factor. Cancer Gene Ther 3:39-4-7
27. Mulé JJ, Yang JC, Afreniere RL, Shu SY, Rosenberg SA (1987) Identification of cellular mechanisms operational in vivo during the regression of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin 2. J Immunol 139:285-294
28. Rutella S, Danese S, Leone G (2006) Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 108:1435-1440 (Pubitemid 44316106)
29. Akbari O, DeKruyff RH, Umetsu DT (2001) Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2:725-731 (Pubitemid 32747162)
30. Ruedl C, Koebel P, Bachmann M, Hess M, Karjalainen K (2000) Anatomical origin of dendritic cells determines their life span in peripheral lymph nodes. J Immunol 165:4910-4916
31. Brand CU, Hunger RE, Yawalkar N, Gerber HA, Schaffner T, Braathen LR (1999) Characterization of human skin-derived CD1a-positive lymph cells. Arch Dermatol Res 291:65-72 (Pubitemid 29116519)
32. Voigtlander C, Rossner S, Cierpka E, Theiner G, Wiethe C, Menges M, Schuler G, Lutz MB (2006) Dendritic cells matured with TNF can be further activated in vitro and after subcutaneous injection in vivo which converts their tolerogenicity into immunogenicity. J Immunother 29:407-415 (Pubitemid 44288953)
33. Pilon-Thomas S, Verhaegen M, Kuhn L, Riker A, Mulé JJ (2006) Induction of anti-tumor immunity by vaccination with dendritic cells pulsed with anti-CD44 IgG opsonized tumor cells. Cancer Immunol Immunother 55:1238-1246 (Pubitemid 43992050)
34. Wei H, Wang H, Lu B, Li B, Hou S, Qian W, Fan K, Dai J, Zhao J, Guo Y (2008) Cancer immunotherapy using in vitro genetically modified targeted dendritic cells. Cancer Res 68:3854-3862
35. Linette GP, Zhang D, Hodi FS, Jonasch EP, Longerich S, Stowell CP, Webb IJ, Daley H, Soiffer RJ, Cheung AM, Eapen SG, Fee SV, Rubin KM, Sober AJ, Haluska FG (2005) Immunization using autologous dendritic cells pulsed with the melanomaassociated antigen gplOO-derived G280-9V peptide elicits CD8+ immunity. Clin Cancer Res 11:7692-7699 (Pubitemid 41611611)
36. Huck SP, Tang SC, Andrew KA, Yang J, Harper JL, Ronchese F (2008) Activation and route of administration both determine the ability of bone marrow-derived dendritic cells to accumulate in secondary lymphoid organs and prime CD8+ T cells against tumors. Cancer Immunol Immunother 57:63-71 (Pubitemid 350043649)
37. Yanagawa Y, Iwabuchi K, Onoe K (2009) Co-operative action of interleukin-10 and interferon-gamma to regulate dendritic cell functions. Immunology 127:345-353
38. Gabrysova L, Nicolson KS, Streeter HB, Verhagen J, SabatosPeyton CA, Morgan DJ, Wraith DC (2009) Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells. J Exp Med 206:1755-1767
39. Ramming A, Thummler K, Schulze-Koops H, Skapenko A (2009) Homotypic T-cell/T-cell interaction induces T-cell activation, proliferation, and differentiation. Hum Immunol 70:873-881
40. Kleindienst P, Wiethe C, Lutz MB, Brocker T (2005) Simultaneous induction of CD4 T-cell tolerance and CD8 T-cell immunity by semimature dendritic cells. J Immunol 174:3941-3947 (Pubitemid 40395968)
41. Haringer B, Lozza L, Steckel B, Geginat J (2009) Identification and characterization of IL-10/IFN-gamma-producing effectorlike T cells with regulatory function in human blood. J Exp Med 206:1009-1017
42. McIlroy D, Gregoire M (2003) Optimizing dendritic cell-based anticancer immunotherapy: maturation state does have clinical impact. Cancer Immunol Immunother 52:583-591 (Pubitemid 37268190)
43. Decker WK, Li S, Xing D, Robinson. SN, Yang H, Steiner D, Komanduri KV, Bollard CM, Schpall EJ (2008) Deficient TH-I responses from TNF-[alpha]-matured and [alpha]-CD40-matured dendritic cells. J Immunother 31:157-165